Literature DB >> 19609535

Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorectal cancer.

Meng-Lin Huang1, Chou-Chan Chen, Li-Ching Chang.   

Abstract

PURPOSE: The high mobility group proteins (HMGs) include the HMGI family members HMGI-C and HMGI(Y), whose expressions in adult tissues generally correlate with malignant tumor phenotypes. The aim of this study was to assess the relationship of HMGI-C or HMGI(Y) gene expression and prognosis in colorectal cancer patients.
METHODS: The gene expressions of HMGI-C and HMGI(Y) in 31 paired samples of colorectal tumor and corresponding non-tumor were determined by real-time reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS: The expression of HMGI(Y) in a colorectal cancer tumor was associated with Dukes staging (p = 0.044), while, in non-tumor, the expression of this gene was significant with metastasis (p = 0.003). Patients with Dukes stage A and B present high HMGI(Y) expression in non-tumor of colorectal cancer (p = 0.006). However, patients with Dukes stage C and D present high HMGI-C expression in colorectal tumor (p = 0.023). In the non-metastasis group, HMGI(Y) was highly expressed in non-tumor of colorectal cancer. However, in the metastasis group, there was no significant difference between tumor and non-tumor tissues in both HMGI-C and HMGI(Y) gene expressions.
CONCLUSIONS: The HMGI-C and HMGI(Y) quantitations by real-time RT-PCR are associated with Dukes staging and metastasis; hence, the gene expression levels may be useful in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19609535     DOI: 10.1007/s00384-009-0770-7

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  32 in total

1.  Oncogenic raf-1 induces the expression of non-histone chromosomal architectural protein HMGI-C via a p44/p42 mitogen-activated protein kinase-dependent pathway in salivary epithelial cells.

Authors:  D Li; H H Lin; M McMahon; H Ma; D K Ann
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

2.  Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker.

Authors:  N Abe; T Watanabe; M Sugiyama; H Uchimura; G Chiappetta; A Fusco; Y Atomi
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

3.  Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations.

Authors:  G Tallini; P Dal Cin; K J Rhoden; G Chiapetta; G Manfioletti; V Giancotti; A Fusco; H Van den Berghe; R Sciot
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

4.  Expression of the HMGI(Y) gene in human colorectal cancer.

Authors:  D H Kim; Y S Park; C J Park; K C Son; E S Nam; H S Shin; J W Ryu; D S Kim; C K Park; Y E Park
Journal:  Int J Cancer       Date:  1999-08-20       Impact factor: 7.396

Review 5.  HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors.

Authors:  G Tallini; P Dal Cin
Journal:  Adv Anat Pathol       Date:  1999-09       Impact factor: 3.875

6.  HMGI(Y) gene expression as a potential marker of thyroid follicular carcinoma.

Authors:  W Czyz; E Balcerczak; M Jakubiak; Z Pasieka; K Kuzdak; M Mirowski
Journal:  Langenbecks Arch Surg       Date:  2004-04-24       Impact factor: 3.445

7.  Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo.

Authors:  S Battista; F de Nigris; M Fedele; G Chiappetta; S Scala; D Vallone; G M Pierantoni; T Mega; M Santoro; G Viglietto; P Verde; A Fusco; T Megar
Journal:  Oncogene       Date:  1998-07-23       Impact factor: 9.867

8.  HMGA2 participates in transformation in human lung cancer.

Authors:  Francescopaolo Di Cello; Joelle Hillion; Alexandra Hristov; Lisa J Wood; Mita Mukherjee; Andrew Schuldenfrei; Jeanne Kowalski; Raka Bhattacharya; Raheela Ashfaq; Linda M S Resar
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

9.  Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas.

Authors:  Monica Fedele; Sabrina Battista; Lawrence Kenyon; Gustavo Baldassarre; Vincenzo Fidanza; Andres J P Klein-Szanto; A F Parlow; Rosa Visone; Giovanna M Pierantoni; Eric Outwater; Massimo Santoro; Carlo M Croce; Alfredo Fusco
Journal:  Oncogene       Date:  2002-05-09       Impact factor: 9.867

10.  Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresis.

Authors:  Takeshi Tomonaga; Kazuyuki Matsushita; Seiko Yamaguchi; Masamichi Oh-Ishi; Yoshio Kodera; Tadakazu Maeda; Hideaki Shimada; Takenori Ochiai; Fumio Nomura
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

View more
  16 in total

1.  Silencing of HMGA1 expression by RNA interference suppresses growth of osteogenic sarcoma.

Authors:  Shaohui Yuan; Qi Pan; Chunjiang Fu; Zhenggang Bi
Journal:  Mol Cell Biochem       Date:  2011-05-15       Impact factor: 3.396

2.  Genome-wide analysis of HMGA2 transcription factor binding sites by ChIP on chip in gastric carcinoma cells.

Authors:  Lang Zha; Ziwei Wang; Weixue Tang; Neng Zhang; Gang Liao; Zhen Huang
Journal:  Mol Cell Biochem       Date:  2012-01-14       Impact factor: 3.396

3.  Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers.

Authors:  Xiaochen Wang; Xiyong Liu; Angela Ying-Jian Li; Lirong Chen; Lily Lai; Her Helen Lin; Shuya Hu; Lifang Yao; Jiaping Peng; Sofia Loera; Lijun Xue; Bingsen Zhou; Lun Zhou; Shu Zheng; Peiguo Chu; Suzhan Zhang; David Kong Ann; Yun Yen
Journal:  Clin Cancer Res       Date:  2011-01-20       Impact factor: 12.531

4.  Molecular profiles and clinical outcome of stage UICC II colon cancer patients.

Authors:  Jörn Gröne; Dido Lenze; Vindi Jurinovic; Manuela Hummel; Henrik Seidel; Gabriele Leder; Georg Beckmann; Anette Sommer; Robert Grützmann; Christian Pilarsky; Ulrich Mansmann; Heinz-Johannes Buhr; Harald Stein; Michael Hummel
Journal:  Int J Colorectal Dis       Date:  2011-04-05       Impact factor: 2.571

5.  siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma.

Authors:  Sahar Esmailzadeh; Behzad Mansoori; Ali Mohammadi; Dariush Shanehbandi; Behzad Baradaran
Journal:  J Gastrointest Cancer       Date:  2017-06

6.  Effect of silencing of high mobility group A2 gene on gastric cancer MKN-45 cells.

Authors:  Chun-Hui Wei; Li-Xiu Wei; Ming-Yu Lai; Jia-Zhuang Chen; Xi-Jing Mo
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

7.  The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.

Authors:  Bethany M Bush; Ashton T Brock; Jiayue A Deng; Ronald A Nelson; Takita Felder Sumter
Journal:  Cell Biochem Funct       Date:  2012-09-07       Impact factor: 3.685

8.  Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer.

Authors:  Dequan Kong; Guoqiang Su; Lang Zha; Hongyu Zhang; Jifeng Xiang; Wei Xu; Yucheng Tang; Ziwei Wang
Journal:  Med Oncol       Date:  2014-07-19       Impact factor: 3.064

9.  HMGA2 is a driver of tumor metastasis.

Authors:  Asahiro Morishita; M Raza Zaidi; Akira Mitoro; Devipriya Sankarasharma; Matthias Szabolcs; Yasunori Okada; Jeanine D'Armiento; Kiran Chada
Journal:  Cancer Res       Date:  2013-05-30       Impact factor: 12.701

10.  HMGA2 Expression in Renal Carcinoma and its Clinical Significance.

Authors:  Ying Liu; Qi-Zhong Fu; Lin Pu; Qing-Guo Meng; Xian-Feng Liu; Sheng-Fang Dong; Jian-Xun Yang; Guang-Yao Lv
Journal:  J Med Biochem       Date:  2015-07-14       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.